Format

Send to

Choose Destination
Life Sci. 2018 Dec 1;214:153-157. doi: 10.1016/j.lfs.2018.10.063. Epub 2018 Oct 29.

Interaction between gut microbiome and cardiovascular disease.

Author information

1
Department of Geriatrics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
2
Laboratory of Clinical Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
3
Department of Geriatrics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China. Electronic address: xiangyuzhang@csu.edu.cn.

Abstract

Traditional cardiovascular risk factors do not underlie all incidence of cardiovascular disease. In recent years, accumulating evidence has demonstrated that gut microbiota and its metabolites also play a pivotal role in the onset and development of cardiovascular disease, including atherosclerosis, hypertension, heart failure, atrial fibrillation and myocardial fibrosis. Trillions of bacteria indwell the gastrointestinal tract and metabolize nutrients into trimethylamine-N-oxide, short-chain fatty acids and so on. Targeting these microorganisms and relevant metabolic pathways has beneficial effects in cardiovascular disease. This review will summarize the role of gut microbiota and its metabolites, mainly trimethylamine-N-oxide, in the pathogenesis of cardiovascular diseases, and discuss the possible mechanisms that drive cardiovascular diseases and highlight potential therapies in this field.

KEYWORDS:

Cardiovascular disease; Gut microbiome; Short-chain fatty acids; Trimethylamine; Trimethylamine‑N‑oxide

PMID:
30385177
DOI:
10.1016/j.lfs.2018.10.063
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center